BENGALURU (Reuters) – The Serum Institute of India is preparing to produce Novavax’s COVID-19 vaccine in the country, government official Vinod Kumar Paul said at a press briefing on Tuesday.
The vaccine maker on Monday had said its COVID-19 vaccine was more than 90% effective in a large, late-stage U.S.-based clinical trial.
(Reporting by Shivani Singh in Bengaluru, editing by Louise Heavens)
Kawhi Leonard is returning to the Clippers’ lineup for Game 2 against Luka Doncic and the Mavericks
Havertz scores 2 as Arsenal routs Chelsea 5-0 to cement Premier League lead
Timberwolves dispute between Taylor and Lore, Rodriguez over ownership moves to mediation
Montana minor league baseball team in dispute with National Park Service over arrowhead logo
Defensemen injuries are already piling up early in the NHL playoffs
With public universities under threat, massive protests against austerity shake Argentina
World seeing near breakdown of international law amid wars in Gaza and Ukraine, Amnesty says
Tennessee lawmakers pass bill to allow armed teachers, a year after deadly Nashville shooting
New federal rule would bar ‘noncompete’ agreements for most employees
Ashley Judd and Aloe Blacc help the White House unveil its national suicide prevention strategy
Ashley Judd and Aloe Blacc help the White House unveil its national suicide prevention strategy
Get better sleep with these 5 tips from experts
What’s EMTALA, the patient protection law at the center of Supreme Court abortion arguments?
Abortion returns to the spotlight in Italy, 46 years after it was legalized
